Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

essential pharma limited vision exchange building, triq it-territorjals, zone 1, central business district cbd 1070 birkirka - lithiumcarbonaat 400 mg/stuk - tablet met gereguleerde afgifte - arabische gom (e 414) ; glycerolpalmitostearaat ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumlaurilsulfaat ; natriumzetmeelglycolaat, arabische gom (e 414) ; glycerolpalmitostearaat ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumlaurilsulfaat (e 487) ; natriumzetmeelglycolaat (e468), - lithium

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

essential pharma limited vision exchange building, triq it-territorjals, zone 1, central business district cbd 1070 birkirka - kaliumchloride (e 508) 600 mg/stuk - tablet met gereguleerde afgifte - arabische gom (e 414) ; carnaubawas (e 903) ; cetostearylalcohol ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; magnesiumstearaat (e 470b) ; saccharose ; talk (e 553 b) ; titaandioxide (e 171), - potassium chloride

Europos Sąjunga - olandų - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - ophthalmologica - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Europos Sąjunga - olandų - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - ophthalmologica - eylea is geïndiceerd bij volwassenen voor de behandeling van:neovascular (natte) leeftijdsgebonden maculaire degeneratie (amd);slechtziendheid als gevolg van maculair oedeem, secundair aan retinale veneuze occlusie (tak rvo of centrale rvo);visuele handicap vanwege diabetisch macula-oedeem (dme);visuele handicap vanwege bijziend choroidale neovascularisation (bijziend cnv).

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

essential pharma limited vision exchange building, triq it-territorjals, zone 1, central business district cbd 1070 birkirka - calcitonine, zalm 100 ie/ml - oplossing voor injectie, oplossing voor infusie - azijnzuur (e 260), geconcentreerd ; natriumacetaat 3-water (e 262) ; natriumchloride ; stikstof (head space) (e 941) ; water voor injectie, azijnzuur (e 260), geconcentreerd ; natriumacetaat 3-water (e 262) ; natriumchloride ; stikstof (head space) (e 941) ; water, gezuiverd, - calcitonin (salmon synthetic)

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

essential pharma limited vision exchange building, triq it-territorjals, zone 1, central business district cbd 1070 birkirka - lithiumcarbonaat 250 mg/stuk - tablet - hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; macrogol 400 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; maÏszetmeel, gepregelatineerd, - lithium

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

essential pharma limited vision exchange building, triq it-territorjals, zone 1, central business district cbd 1070 birkirka - docusaat natrium 12 mg/g - gel voor rectaal gebruik - carmellose natrium (e 466) ; glycerol (e 422) ; water, gezuiverd, - docusate sodium, incl. combinations

Europos Sąjunga - olandų - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - ophthalmologica - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Europos Sąjunga - olandų - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Europos Sąjunga - olandų - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).